%0 Journal Article
%T Powerful Efficacy of GCSB-5 Treatment for Improving Fatigue and Motor Function in Multiple Sclerosis (MS): A Randomized Double Blind, Place-bo-Controlled Study
%A Ji Yun Shin
%J Open Access Library PrePrints
%V 2
%N 1
%P 1-10
%@ 2333-9721
%D 2016
%I Open Access Library
%R 10.4236/oalib.preprints.1200150
%X <div style="text-align:justify;">
	<span style="line-height:1.5;">Multiple
Sclerosis (MS) is the most common disability in young adults that requires
early symptomatic treatment to prevent long-term disability. Among young
adults, MS is the most common central nerv-ous system (CNS) chronic
inflammatory illness that is characterized by demyelination in the CNS.
However, current disease-modifying treatments are not sufficiently effective
for preventing the variety of symptoms during the co</span><span style="line-height:1.5;">urse of disease.</span>
</div>
%K Multiple Sclerosis
%K GCSB-5 Treatment
%U http://www.oalib.com/paper/5274993